Hands-on Training in Recombinant Protein Production: Advancing Vaccine Manufacturing Independence in Africa (Series 1)

The KAVI-Institute of Clinical Research, in collaboration with BioStruct-Africa, will host a week-long hands-on training workshop focused on recombinant protein production as a strategic tool for strengthening vaccine manufacturing capacity in Africa.

Building Africa’s Clinical Trials Workforce: KAVI-ICR Hosts Regional Clinical Trial Monitoring Course in Nairobi

This week, KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, in partnership with ClinWin Research Services, is hosting a high-impact Clinical Trial Monitoring Course in Nairobi, bringing together early-career and experienced professionals from across the region. The course is part of a long-standing collaboration between KAVI-ICR and ClinWin focused on strengthening Africa’s clinical research ecosystem through practical, skills-based training and mentorship. 

KAVI-ICR Advances Biosafety Through ISO 35001 Implementation Initiative

KAVI-Institute of Clinical Research (KAVI-ICR) continues to demonstrate leadership in laboratory biosafety and biosecurity through its participation in the CEPI ISO 35001 Implementation Project. Representatives from KAVI-ICR, including its founder, Professor Omu Anzala, and Laboratory Technologist Dennis Chalo, attended a high-level coordination meeting at the National Institute for Communicable Diseases in Johannesburg from March 30 to April 1, 2026.

Advancing HIV Vaccine Science: KAVI-ICR Researchers Participate in the IAS HIV Vaccine Science Academy 2026

From 10–12 March 2026, researchers from KAVI-Institute of Clinical Research (KAVI-ICR) actively participated in the HIV Vaccine Science Academy held in Dar es Salaam, Tanzania. The academy, organized by the International AIDS Society, brought together early-career scientists and leading global experts to explore the latest advances in HIV vaccine research.